Literature DB >> 3264787

Germline antibody V regions as determinants of clonal persistence and malignant growth in the B cell compartment.

I Förster1, H Gu, K Rajewsky.   

Abstract

Antibody V gene expression was studied in a subpopulation of murine B cells (Ly1 B) which was enriched by cell transfer and had earlier been shown to persist in the immune system over long periods of time. Among 17 hybridomas derived from Ly1 B cells of two different mice, eight were progeny of only three different B cell precursors which apparently had expanded to clones of large size, in the absence of detectable somatic mutation of their antibody V regions. Furthermore, several clonally independent cells expressed identical, unmutated V genes. These data define a novel pathway of B cell development in which cells expressing a selected set of germline antibodies are continuously propagated in the organism. A Ly1 B cell leukemia derived from a similar transfer experiment expressed a VH gene that had been isolated in three independent Ly1 B cell hybridomas, suggesting that the leukemic cells had been equally selected in this pathway.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3264787      PMCID: PMC454942          DOI: 10.1002/j.1460-2075.1988.tb03251.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  72 in total

1.  Evolution of pseudogenes in the immunoglobulin VH-gene family of the mouse.

Authors:  T Blankenstein; F Bonhomme; U Krawinkel
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

Review 2.  Antigen-driven selection of virgin and memory B cells.

Authors:  I C MacLennan; D Gray
Journal:  Immunol Rev       Date:  1986-06       Impact factor: 12.988

3.  Functional characterization of monoclonal auto-anti-idiotype antibodies isolated from the early B cell repertoire of BALB/c mice.

Authors:  M Vakil; J F Kearney
Journal:  Eur J Immunol       Date:  1986-09       Impact factor: 5.532

Review 4.  Development of the primary antibody repertoire.

Authors:  F W Alt; T K Blackwell; G D Yancopoulos
Journal:  Science       Date:  1987-11-20       Impact factor: 47.728

5.  Ly-1 as a differentiation antigen on normal and neoplastic B cells.

Authors:  R R Hardy; K Hayakawa; L A Herzenberg; H C Morse; W F Davidson; L A Herzenberg
Journal:  Curr Top Microbiol Immunol       Date:  1984       Impact factor: 4.291

Review 6.  Lymphocyte population kinetics in the mouse.

Authors:  A A Freitas; B Rocha; A A Coutinho
Journal:  Immunol Rev       Date:  1986-06       Impact factor: 12.988

7.  Ly-1 B cells: functionally distinct lymphocytes that secrete IgM autoantibodies.

Authors:  K Hayakawa; R R Hardy; M Honda; L A Herzenberg; A D Steinberg; L A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

8.  A unique series of lymphomas related to the Ly-1+ lineage of B lymphocyte differentiation.

Authors:  W F Davidson; T N Fredrickson; E K Rudikoff; R L Coffman; J W Hartley; H C Morse
Journal:  J Immunol       Date:  1984-08       Impact factor: 5.422

9.  A V region determinant (idiotope) expressed at high frequency in B lymphocytes is encoded by a large set of antibody structural genes.

Authors:  R Dildrop; J Bovens; M Siekevitz; K Beyreuther; K Rajewsky
Journal:  EMBO J       Date:  1984-03       Impact factor: 11.598

10.  Variable region sequences of murine IgM anti-IgG monoclonal autoantibodies (rheumatoid factors). A structural explanation for the high frequency of IgM anti-IgG B cells.

Authors:  M J Shlomchik; D A Nemazee; V L Sato; J Van Snick; D A Carson; M G Weigert
Journal:  J Exp Med       Date:  1986-08-01       Impact factor: 14.307

View more
  39 in total

1.  Tumorigenesis mediated by an antigen receptor.

Authors:  H M Jäck; G Beck-Engeser; G Lee; D Wofsy; M Wabl
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

Review 2.  Pairing of VK and VK gene families in self-reactive antibodies.

Authors:  C A Bona; Y Saitoh; G Kelsoe
Journal:  J Clin Immunol       Date:  1990-09       Impact factor: 8.317

3.  Differential development of progenitor activity for three B-cell lineages.

Authors:  A B Kantor; A M Stall; S Adams; L A Herzenberg; L A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

4.  Relationship of the CD5 B cell to human tonsillar lymphocytes that express autoantibody-associated cross-reactive idiotypes.

Authors:  T J Kipps; S F Duffy
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

5.  Molecular single-cell analysis reveals that CD5-positive peripheral blood B cells in healthy humans are characterized by rearranged Vkappa genes lacking somatic mutation.

Authors:  M Fischer; U Klein; R Küppers
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

Review 6.  From pathogenesis to treatment of chronic lymphocytic leukaemia.

Authors:  Thorsten Zenz; Daniel Mertens; Ralf Küppers; Hartmut Döhner; Stephan Stilgenbauer
Journal:  Nat Rev Cancer       Date:  2009-12-03       Impact factor: 60.716

Review 7.  Abnormalities in the regulation of variable region genes that encode for antibodies to DNA may be a central factor in the pathogenesis of systemic lupus erythematosus.

Authors:  A K Singh
Journal:  Ann Rheum Dis       Date:  1993-05       Impact factor: 19.103

8.  Adult BM generates CD5+ B1 cells containing abundant N-region additions.

Authors:  Nichol E Holodick; Karen Repetny; Xuemei Zhong; Thomas L Rothstein
Journal:  Eur J Immunol       Date:  2009-09       Impact factor: 5.532

9.  Distinctions among Circulating Antibody-Secreting Cell Populations, Including B-1 Cells, in Human Adult Peripheral Blood.

Authors:  Tâm D Quách; Nely Rodríguez-Zhurbenko; Thomas J Hopkins; Xiaoti Guo; Ana María Hernández; Wentian Li; Thomas L Rothstein
Journal:  J Immunol       Date:  2016-01-06       Impact factor: 5.422

Review 10.  Perspectives on fetal derived CD5+ B1 B cells.

Authors:  Richard R Hardy; Kyoko Hayakawa
Journal:  Eur J Immunol       Date:  2015-09-23       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.